Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Peter S. Winter"'
Autor:
Lydie Debaize, Ye Zhang, Michelle Ramseier, Mingzeng Zhang, Adam Langenbucher, Peter S. Winter, Ran Xu, Nezha Senhaji, Robert A Redd, Martin J. Aryee, Paul H. Branch, Austin I. Kim, David M. Weinstock, Alex Shalek, Scott R. Manalis, Mark A. Murakami
Publikováno v:
HemaSphere, Vol 7, p e96705d3 (2023)
Externí odkaz:
https://doaj.org/article/713cb23b4f6148cd99681bf90cefde7a
Autor:
Ryan S. Soderquist, Lorin Crawford, Esther Liu, Min Lu, Anika Agarwal, Grace R. Anderson, Kevin H. Lin, Peter S. Winter, Merve Cakir, Kris C. Wood
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Dependency of diverse cancers on specific BCL-2 family members and their combinations is unknown. Here they perform drug screening and find most cell lines to be dependent on at least one combination of BCL-2 family members, and using a CRISPR screen
Externí odkaz:
https://doaj.org/article/d950f5d4286b4fd19e6d199b06c153c5
Autor:
Grace R. Anderson, Peter S. Winter, Kevin H. Lin, Daniel P. Nussbaum, Merve Cakir, Elizabeth M. Stein, Ryan S. Soderquist, Lorin Crawford, Jim C. Leeds, Rachel Newcomb, Priya Stepp, Catherine Yip, Suzanne E. Wardell, Jennifer P. Tingley, Moiez Ali, Mengmeng Xu, Meagan Ryan, Shannon J. McCall, Autumn J. McRee, Christopher M. Counter, Channing J. Der, Kris C. Wood
Publikováno v:
Cell Reports, Vol 20, Iss 4, Pp 999-1015 (2017)
Combinatorial inhibition of effector and feedback pathways is a promising treatment strategy for KRAS mutant cancers. However, the particular pathways that should be targeted to optimize therapeutic responses are unclear. Using CRISPR/Cas9, we system
Externí odkaz:
https://doaj.org/article/a9b233c46180479b811cfec67978789b
Autor:
Benjamin Mayro, Jacob P. Hoj, Christian G. Cerda-Smith, Haley M. Hutchinson, Michael W. Caminear, Hannah L. Thrash, Peter S. Winter, Suzanne E. Wardell, Donald P. McDonnell, Colleen Wu, Kris C. Wood, Ann Marie Pendergast
Publikováno v:
Proceedings of the National Academy of Sciences. 120
The hypoxia-inducible factor 1-α (HIF-1α) enables cells to adapt and respond to hypoxia (Hx), and the activity of this transcription factor is regulated by several oncogenic signals and cellular stressors. While the pathways controlling normoxic de
Autor:
Donald P. McDonnell, Jay C. Strum, Scott A. Lawrence, Rigel J. Kishton, Kimberly J. Cocce, Peter S. Winter, Rachid Safi, Hannah S. White, Victoria O. Haney, Holly M. Alley, Alexander P. Yllanes, John D. Norris, Suzanne E. Wardell, James P. Stice
Resistance to second-generation androgen receptor (AR) antagonists and CYP17 inhibitors in patients with castration-resistant prostate cancer (CRPC) develops rapidly through reactivation of the androgen signaling axis and has been attributed to AR ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::997103967b585ac8b172658ecb3b7484
https://doi.org/10.1158/1541-7786.c.6541489
https://doi.org/10.1158/1541-7786.c.6541489
Autor:
Donald P. McDonnell, Jay C. Strum, Scott A. Lawrence, Rigel J. Kishton, Kimberly J. Cocce, Peter S. Winter, Rachid Safi, Hannah S. White, Victoria O. Haney, Holly M. Alley, Alexander P. Yllanes, John D. Norris, Suzanne E. Wardell, James P. Stice
Contains legends to supplementary figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46f3a7d6a33693b28b5123409ea4c0b
https://doi.org/10.1158/1541-7786.22516804.v1
https://doi.org/10.1158/1541-7786.22516804.v1
Autor:
Donald P. McDonnell, Jay C. Strum, Scott A. Lawrence, Rigel J. Kishton, Kimberly J. Cocce, Peter S. Winter, Rachid Safi, Hannah S. White, Victoria O. Haney, Holly M. Alley, Alexander P. Yllanes, John D. Norris, Suzanne E. Wardell, James P. Stice
Supplemental Figure 1. The effects of G1T28 are due to CDK4/6 inhibition. Supplemental Figure 2. Analysis of pharmacodynamics endpoints indicates on-target activity in 22Rv1 tumors. A. Supplemental Figure 3. G1T38 and G128 have similar in vitro effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d35094806626b4a693938067925dfd
https://doi.org/10.1158/1541-7786.22516801.v1
https://doi.org/10.1158/1541-7786.22516801.v1
Autor:
Brian M. Wolpin, Jonathan A. Nowak, Andrew J. Aguirre, Alex K. Shalek, William C. Hahn, Aram F. Hezel, Albert C. Koong, Daniel T. Chang, Richard F. Dunne, David C. Linehan, Margaret M. Kozak, Emma R. Hill, Lauren K. Brais, Joseph D. Mancias, Jiping Wang, Thomas E. Clancy, James M. Cleary, Kimberly Perez, Harshabad Singh, Douglas A. Rubinson, Vicente Morales-Oyarvide, Dalia Elganainy, Mai Chan Lau, Kristen E. Lowder, Radha L. Kalekar, Timothy L. Bosse, Annan Yang, Junning Wang, Andrew W. Navia, Chen Yuan, Juha P. Väyrynen, Sara A. Väyrynen, Scott P. Ginebaugh, Kevin S. Kapner, Peter S. Winter, Srivatsan Raghavan, Jinming Zhang, Andressa Dias Costa, Hannah L. Williams
Pancreatic ductal adenocarcinoma (PDAC) has been classified into classical and basal-like transcriptional subtypes by bulk RNA measurements. However, recent work has uncovered greater complexity to transcriptional subtypes than was initially apprecia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58901a59881a291461b659642ab759fd
https://doi.org/10.1158/0008-5472.c.6514341.v1
https://doi.org/10.1158/0008-5472.c.6514341.v1
Autor:
Brian M. Wolpin, Jonathan A. Nowak, Andrew J. Aguirre, Alex K. Shalek, William C. Hahn, Aram F. Hezel, Albert C. Koong, Daniel T. Chang, Richard F. Dunne, David C. Linehan, Margaret M. Kozak, Emma R. Hill, Lauren K. Brais, Joseph D. Mancias, Jiping Wang, Thomas E. Clancy, James M. Cleary, Kimberly Perez, Harshabad Singh, Douglas A. Rubinson, Vicente Morales-Oyarvide, Dalia Elganainy, Mai Chan Lau, Kristen E. Lowder, Radha L. Kalekar, Timothy L. Bosse, Annan Yang, Junning Wang, Andrew W. Navia, Chen Yuan, Juha P. Väyrynen, Sara A. Väyrynen, Scott P. Ginebaugh, Kevin S. Kapner, Peter S. Winter, Srivatsan Raghavan, Jinming Zhang, Andressa Dias Costa, Hannah L. Williams
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b8ab2de7cfe7f7ab46e4e9b09fa895
https://doi.org/10.1158/0008-5472.22433331.v1
https://doi.org/10.1158/0008-5472.22433331.v1
Autor:
Benjamin E. Mead, Conner Kummerlowe, Nuo Liu, Walaa E. Kattan, Thomas Cheng, Jaime H. Cheah, Christian K. Soule, Josh Peters, Kristen E. Lowder, Paul C. Blainey, William C. Hahn, Brian Cleary, Bryan Bryson, Peter S. Winter, Srivatsan Raghavan, Alex K. Shalek
Publikováno v:
bioRxiv
High-throughput phenotypic screens leveraging biochemical perturbations, high-content readouts, and complex multicellular models could advance therapeutic discovery yet remain constrained by limitations of scale. To address this, we establish a metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd9ca0ca92084b2eca2635e8e0d40b7
https://europepmc.org/articles/PMC9900857/
https://europepmc.org/articles/PMC9900857/